CD163 and neoplasm: A high CD163+/CD68+ TAM ratio at the tumor front was associated with worse survival in a study investigating Stage I–III CRC (n = 81), whereas no such association was observed when a high CD163+/CD68+ TAM ratio was found intratumorally [38].